Persistent lowering of arterial pressure after continuous and intermittent therapy

Journal of Hypertension

Volumn 21, Issue 4, 2003, Pages 813-820

  Woolard, Jeanette ^a   Hale, Taben M ^a   Bushfield, Terri L ^a   Adams, Michael A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Antihypertensive therapy; Blood pressure; Hypertension; Inbred spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LOSARTAN; NIFEDIPINE; VASODILATOR AGENT;

ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTENSION; INBRED STRAIN; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY; TREATMENT OUTCOME;

EID: 0038031715     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200304000-00026     Document Type: Conference Paper

References (41)

1. Adams MA, Bobik A, Korner PI. Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension 1990; 16:252-260.
2. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 1989; 7:83-90.
3. Dukacz SA, Adams MA, Kline RL. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats. Am J Physiol 1997; 273:F104-F112.
4. Lundie MJ, Friberg P, Kline RL, Adams MA. Long-term inhibition of the renin-angiotensin system in genetic hypertension: analysis of the impact on blood pressure and cardiovascular structural changes. J Hypertens 1997; 15:339-348.
5. Dukacz SA, Adams MA, Kline RL. Short- and long-term enalapril affect renal medullary hemodynamics in the spontaneously hypertensive rat. Am J Physiol 1999; 276:R10-R16.
6. Christensen HR, Nielsen H, Christensen KL, Baandrup U, Jespersen LT, Mulvany MJ. Long-term hypotensive effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: is there a role for vascular structure? J Hypertens Suppl 1988; 6:S27-S31.
7. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990; 16:603-614.
8. Nyborg NC, Mulvany MJ. Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovasc Res 1985; 19:528-536.
9. Schiffrin EL. Small artery remodeling in hypertension: can it be corrected? Am J Med Sci 2001; 322:7-11.
10. Freslon JL, Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharm 1983; 80:533-543.
11. Heller J, Hellerova S. Long-term effect on blood pressure of early brief treatment by different antihypertensive agents: a study in the Prague hypertensive rat. Kidney Blood Press Res 1998; 21:445-451.
12. Weiss L. Long-term treatment with antihypertensive drugs in spontaneously hypertensive rats (SHR). Effects on blood pressure, survival rate and cardiovascular design. Acta Physiol Scand 1974; 91:393-408.
13. Weiss L, Lundgren Y, Folkow B. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR). Acta Physiol Scand 1974; 91:447-457.
14. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti R. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension 1994; 24:131-139.
15. deBlois D, Tea BS, Than VD, Tremblay J, Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 1997; 29:340-349.
16. Brockway BP, Mills PA, Azar SH. A new method for continuous chronic measurement and recording of blood pressure, heart rate and activity in the rat via radio-telemetry. Clin Exp Hypertens A 1991; 13:885-895.
17. Schnell CR, Wood JM. Measurement of blood pressure and heart rate by telemetry in conscious, unrestrained marmosets. Am J Physiol 1993; 264:H1509-H1516.
18. Stocker SD, Sved AF, Stricker EM. Role of renin-angiotensin system in hypotension-evoked thirst: studies with hydralazine. Am J Physiol Regul Integr Comp Physiol 2000; 279:R576-R585.
19. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Jensen G, Friberg P. Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension. Hypertension 2000; 36:543-548.
20. Fiad TM, Cunningham SK, Hayes FJ, McKenna TJ. Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis. J Clin Endocrinol Metab 1997; 82:457-460.
21. Ohman KP, Weiner L, Schenck H von, Karlberg BE. Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension. Eur J Clin Pharm 1985; 29:149-154.
22. Koenig W, Binner L, Gabrielsen F, Sund M, Rosenthal J, Hombach V. Catecholamines and the renin-angiotensin-aldosterone system during treatment with felodipine ER or hydrochlorothiazide in essential hypertension. J Cardiovasc Pharm 1991; 18:349-353.
23. Chalmers JP, Wing LM, West MJ, Bune AJ, Elliott JM, Morris MJ, et al. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension; a double blind factorial cross-over study. Aust N Z J Med 1986; 16:475-480.
24. Hale TM, Okabe H, Heaton JP, Adams MA. Antihypertensive drugs induce structural remodeling of the penile vasculature. J Urol 2001; 166:739-745.
25. Susic D, Aristizabal DJ, Prakash O, Nunez E, Frohlich ED. Early genes induction in spontaneously hypertensive rats left ventricle with angiotensin-converting enzyme inhibitors but not hydralazine. Proc Soc Exp Biol Med 1995; 210:266-269.
26. Reddy DS, Singh M, Ganguly NK. Effects of long-term hydralazine treatment on myocardial structure and expression of myosin isogenes in cardiac pressure overload in rats. Methods Find Exp Clin Pharm 1996; 18:261-271.
27. Mitchell GF, Pfeffer MA, Finn PV, Pfeffer JM. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Circulation 1996; 94:2923-2929.
28. Anderson NH, Devlin AM, Graham D, Morton JJ, Hamilton CA, Reid JL, et al. Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis. Hypertension 1999; 33:248-255.
29. Tamura T, Said S, Harris J, Lu W, Gerdes AM. Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation 2000; 102:253-259.
30. Banting JD, Thompson KE, Friberg P, Adams MA. Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade. Hypertension 1997; 30:416-421.
31. Arnal JF, el Amrani AI, Chatellier G, Menard J, Michel JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 1993; 22:380-387.
32. Morgan TO, Aubert JF, Wang Q. Sodium, angiotensin II, blood pressure, and cardiac hypertrophy. Kidney Int Suppl 1998; 67:S213-S215.
33. Cutilletta AF, Erinoff L, Heller A, Low J, Oparil S. Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy. Circ Res 1977; 40:428-434.
34. Yuan BX, Leenen FH. Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am J Physiol 1991; 261:H1397-H1401.
35. Tsoporis J, Fields N, Lee RM, Leenen FH. Opposite effects of arterial vasodilators on cardiac versus arterial hypertrophy and sympathetic activity in spontaneously hypertensive rats. J Cardiovasc Pharm 1991; 17(suppl 2):S169-S171.
36. Tsoporis J, Fields N, Leenen FH. Contrasting effects of calcium antagonists versus arterial vasodilators on cardiac anatomy and sympathetic activity in spontaneously hypertensive rats. J Cardiovasc Pharm 1991; 17(suppl 2):S166-S168.
37. Tsoporis J, Fields N, Lee RM, Leenen FH. Arterial vasodilation and cardiovascular structural changes in normotensive rats. Am J Physiol 1991; 260:H1944-H1952.
38. Korner PI, Jennings GL, Esler MD, Broughton A. Role of cardiac and vascular amplifiers in the maintenance of hypertension and the effect of reversal of cardiovascular hypertrophy. Clin Exp Pharm Physiol 1985; 12:205-209.
39. Korner PI. Cardiovascular hypertrophy and hypertension: causes and consequences. Blood Press Suppl 1995; 2:6-16.
40. Buus CL, Pourageaud F, Fazzi GE, Janssen G, Mulvany MJ, De Mey JG. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res 2001; 89:180-186.
41. Folkow B, Gurevich M, Hallback M, Lundgren Y, Weiss L. The hemodynamic consequences of regional hypotension in spontaneously hypertensive and normotensive rats. Acta Physiol Scand 1971; 83:532-541.